Bristol Myers Squibb (BMY)

Cash & Short-Term Investments

$11.07B

Quarterly · Period ending: · USD

BMY logo

BMY Cash & Short-Term Investments

Latest reported$11.07B
BMY Quarterly Cash & Short-Term Investments ($2.35B → $11.07B)
High-resolution chart · PNG

BMY cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
11,067,000,000
10,486,000,000
10,673,000,000
16,502,000,000
13,603,000,000
11,782,000,000
10,859,000,000
8,094,000,000
6,653,000,000
9,670,000,000
12,280,000,000
7,685,000,000
8,730,000,000
9,269,000,000
9,253,000,000
9,027,000,000
13,266,000,000
15,196,000,000
17,221,000,000
15,823,000,000
14,016,000,000
13,137,000,000
16,450,000,000
21,281,000,000
21,793,000,000
18,322,000,000
15,393,000,000
32,542,000,000
29,357,000,000
8,764,000,000
8,759,000,000
6,830,000,000
6,075,000,000
6,770,000,000
6,812,000,000
7,122,000,000
6,505,000,000
6,109,000,000
6,350,000,000
5,560,000,000
4,651,000,000
4,307,000,000
4,270,000,000
5,413,000,000
5,476,000,000
7,607,000,000
7,435,000,000
7,221,000,000
7,175,000,000
7,059,000,000
4,525,000,000
2,722,000,000
2,799,000,000
2,533,000,000
2,829,000,000
2,930,000,000
5,037,000,000
5,029,000,000
8,733,000,000
8,193,000,000
7,670,000,000
6,793,000,000
7,301,000,000
8,359,000,000
7,454,000,000
6,776,000,000
8,514,000,000
6,669,000,000
8,120,000,000
8,920,000,000
8,265,000,000
7,431,000,000
4,402,000,000
2,637,000,000
2,225,000,000
3,582,000,000
4,646,000,000
4,012,000,000
4,013,000,000
5,505,000,000
5,357,000,000
5,281,000,000
5,799,000,000
3,781,000,000
3,040,000,000
5,982,000,000
7,474,000,000
7,253,000,000
6,844,000,000
6,617,000,000
5,562,000,000
5,039,000,000
4,421,000,000
4,348,000,000
3,989,000,000
3,597,000,000
3,619,000,000
3,580,000,000
5,654,000,000
3,080,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.